120 related articles for article (PubMed ID: 10561690)
21. Molecular alterations resulting from frameshift mutations in peripheral myelin protein 22: implications for neuropathy severity.
Johnson JS; Roux KJ; Fletcher BS; Fortun J; Notterpek L
J Neurosci Res; 2005 Dec; 82(6):743-52. PubMed ID: 16273544
[TBL] [Abstract][Full Text] [Related]
22. Duplication analysis in Turkish Charcot-Marie-Tooth type 1A patients using short tandem repeat markers.
Koç F; Güzel AI; Sarica Y; Kasap H
Int J Neurosci; 2007 Nov; 117(11):1611-9. PubMed ID: 17917930
[TBL] [Abstract][Full Text] [Related]
23. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of Schwann cell lines as model systems for myelin gene transcription studies.
Hai M; Muja N; DeVries GH; Quarles RH; Patel PI
J Neurosci Res; 2002 Aug; 69(4):497-508. PubMed ID: 12210843
[TBL] [Abstract][Full Text] [Related]
25. The molecular genetics of myelination: an update.
Lemke G
Glia; 1993 Apr; 7(4):263-71. PubMed ID: 7686535
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A).
Sereda MW; Meyer zu Hörste G; Suter U; Uzma N; Nave KA
Nat Med; 2003 Dec; 9(12):1533-7. PubMed ID: 14608378
[TBL] [Abstract][Full Text] [Related]
27. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
Müller HW
Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
[TBL] [Abstract][Full Text] [Related]
28. COPS3 amplification and clinical outcome in osteosarcoma.
Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
[TBL] [Abstract][Full Text] [Related]
29. Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions.
Li J; Kleeff J; Esposito I; Kayed H; Felix K; Giese T; Büchler MW; Friess H
J Histochem Cytochem; 2005 Jul; 53(7):885-93. PubMed ID: 15995147
[TBL] [Abstract][Full Text] [Related]
30. Altered subcellular localization and low frequency of mutations of ING1 in human brain tumors.
Vieyra D; Senger DL; Toyama T; Muzik H; Brasher PM; Johnston RN; Riabowol K; Forsyth PA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5952-61. PubMed ID: 14676120
[TBL] [Abstract][Full Text] [Related]
31. Capillary electrophoresis for the detection of PMP22 gene duplication: study in Mexican patients.
Hernández-Zamora E; de la Luz Arenas-Sordo M; Maldonado-Rodríguez R
Electrophoresis; 2008 Apr; 29(7):1582-4. PubMed ID: 18318003
[TBL] [Abstract][Full Text] [Related]
32. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
[TBL] [Abstract][Full Text] [Related]
33. A new quantitative PCR multiplex assay for rapid analysis of chromosome 17p11.2-12 duplications and deletions leading to HMSN/HNPP.
Thiel CT; Kraus C; Rauch A; Ekici AB; Rautenstrauss B; Reis A
Eur J Hum Genet; 2003 Feb; 11(2):170-8. PubMed ID: 12634865
[TBL] [Abstract][Full Text] [Related]
34. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of a novel BR-2 gene that is down-regulated in human low grade glioma tumors.
Wei KC; Berger MS; Sehgal A
Anticancer Res; 2002; 22(2A):649-57. PubMed ID: 12014633
[TBL] [Abstract][Full Text] [Related]
36. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
37. Molecular basis of hereditary neuropathies.
Chance PF
Phys Med Rehabil Clin N Am; 2001 May; 12(2):277-91. PubMed ID: 11345007
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
Choi BO; Lee MS; Shin SH; Hwang JH; Choi KG; Kim WK; Sunwoo IN; Kim NK; Chung KW
Hum Mutat; 2004 Aug; 24(2):185-6. PubMed ID: 15241803
[TBL] [Abstract][Full Text] [Related]
39. Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas.
Hagemann C; Anacker J; Gerngras S; Kühnel S; Said HM; Patel R; Kämmerer U; Vordermark D; Roosen K; Vince GH
Oncol Rep; 2008 Aug; 20(2):301-8. PubMed ID: 18636190
[TBL] [Abstract][Full Text] [Related]
40. [Detection of duplications or deletions of the PMP22 gene using real-time quantitative PCR].
Zhang FF; Tang BS; Shen Y; Zhao GH; Xia K; Zhao YQ; Chen B; Zhang C; Pan Q; Cai F; Liu XM; Luo W; Zhang RX; Guo P
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Oct; 22(5):537-40. PubMed ID: 16215943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]